MITOXANTRONE - AN ACTIVE AGENT IN REFRACTORY NON-HODGKINS LYMPHOMAS

[1] ABRAHAMSEN AF, 1987, 3RD INT C MAL LYMPH, P149

[2] ALBERTS DS, 1985, INVEST NEW DRUG, V3, P101

[3] COLTMAN CA, 1984, SEMIN ONCOL, V11, P50

[4] DEJAGER R, 1984, EUR J CANCER CLIN ON, V20, P1369, DOI 10.1016/0277-5379(84)90055-5

[5] FUJIMOTO S, 1982, CANCER CHEMOTH PHARM, V8, P157

[6] GAMS RA, 1985, INVEST NEW DRUG, V3, P219

[7] JOHNSON RK, 1979, CANCER TREAT REP, V63, P425

[8] INTERACTIONS OF A NEW ANTI-TUMOR AGENT,1,4-DIHYDROXY-5,8-BIS[[2-[(2-HYDROXYETHYL)AMINO]-ETHYL]AMINO]-9,10-ANTHRACENEDIONE, WITH NUCLEIC-ACIDS [J]. BIOCHEMICAL PHARMACOLOGY, 1981, 30 (03) : 231 - 240

[9] WEEKLY MITOXANTRONE THERAPY OF HODGKINS-DISEASE, NON-HODGKINS-LYMPHOMA, AND CHRONIC LYMPHOCYTIC-LEUKEMIA - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (03): : 194 - 195

[10] KIMLER BF, 1981, CANCER CLIN TRIALS, V4, P173

[1] ABRAHAMSEN AF, 1987, 3RD INT C MAL LYMPH, P149

[2] ALBERTS DS, 1985, INVEST NEW DRUG, V3, P101

[3] COLTMAN CA, 1984, SEMIN ONCOL, V11, P50

[4] DEJAGER R, 1984, EUR J CANCER CLIN ON, V20, P1369, DOI 10.1016/0277-5379(84)90055-5

[5] FUJIMOTO S, 1982, CANCER CHEMOTH PHARM, V8, P157

[6] GAMS RA, 1985, INVEST NEW DRUG, V3, P219

[7] JOHNSON RK, 1979, CANCER TREAT REP, V63, P425

[8] INTERACTIONS OF A NEW ANTI-TUMOR AGENT,1,4-DIHYDROXY-5,8-BIS[[2-[(2-HYDROXYETHYL)AMINO]-ETHYL]AMINO]-9,10-ANTHRACENEDIONE, WITH NUCLEIC-ACIDS [J]. BIOCHEMICAL PHARMACOLOGY, 1981, 30 (03) : 231 - 240

[9] WEEKLY MITOXANTRONE THERAPY OF HODGKINS-DISEASE, NON-HODGKINS-LYMPHOMA, AND CHRONIC LYMPHOCYTIC-LEUKEMIA - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (03): : 194 - 195

[10] KIMLER BF, 1981, CANCER CLIN TRIALS, V4, P173